Cibus Inc., in collaboration with S&W Seed Company, has announced the successful completion of the U.S. Food and Drug Administration's Plant Biotechnology Consultation Program for their altered lignin alfalfa. This regulatory milestone allows for the U.S. commercialization of the alfalfa variant, which offers improved digestibility for livestock and increased harvest flexibility for farmers. The FDA's approval confirms that the altered lignin alfalfa is suitable for food and feed applications. This development underscores Cibus's commitment to advancing agricultural traits that benefit both farmers and the broader value chain.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.